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INTRODUCTION
Despite over 3,000 peer-reviewed articles on
procalcitonin (PCT) since 2004, guidance on its usage
is sparse.1 An analysis of more than 500 United States
hospitals in the Premier Healthcare Database found
large differences in utilization exist across regions (115
PCT encounters per 10,000 patients in the Northeast vs.
408 to 576 in other regions) and teaching vs.
non-teaching hospitals (345 vs. 530 PCT encounters
per 10,000 patients, respectively).2 The purpose of this
work is to describe a case that exemplifies the caveats
in PCT interpretation and to summarize the current
knowledge of the clinical utilization of PCT.

CASE PRESENTATION
A 78-year-old male with a history of hypothyroidism,
Lewy body dementia and long-term central venous
access for nutritional infusions was admitted for the
radiologically-guided placement of drains into newly
found intra-abdominal abscesses seen at an outside
hospital. On presentation he was nonverbal. Family
reported the abscesses were found incidentally; the
patient had not displayed any different behaviors or
symptoms. He had begun receiving ertapenem for
seven days prior to admission. His home medications
included anastrazole, Westhroid TM (a pork thyroid
preparation), and supplemental nutrients including
bearberry leaf extract, CoQ-10, cholecalciferol, boron,
huperzine serrate, EndefenTM, L-carnitine, niacin, DHEA,
and taurine.
On admission, his vitals included temperature 96.2° F,
heart rate 80 beats per minute, blood pressure 121/55
mmHg, respiratory rate 18 breaths per minute, and
SpO2 of 97% on room air. Physical exam revealed a frail
and cachectic, but non-toxic appearing elderly man
with diffuse abdominal tenderness. Laboratory studies
were notable for white blood cell count 20.6 x 109/L
[4,000-11,000 x 109/L] with 87.0% neutrophils [40-80%]
on automated differential (manual differential not
performed for band forms), hemoglobin 9.2 g/dL
[13.5-16.5 g/dL], platelets 422 x 109/L [150-450 x 109/L],
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sodium 135 mmol/L [135-145 mmol/L], bicarbonate 24
mmol/L [22-32 mmol/L], normal anion gap, blood urea
nitrogen 11 mg/dL [7-20 mg/dL], creatinine 1.0 mg/dL
[0.6-1.2], normal liver enzymes and coagulation studies.
C-reactive protein was 5.50 mg/dL. Erythrocyte
sedimentation rate was 80 mm/hr. TSH was 43.15 µIU/
mL with a low T4 of 0.4 ng/dL. Procalcitonin was 0.07
ng/mL (upper limit of normal 0.09 ng/mL).
CT of the abdomen and pelvis showed four fluid
collections concerning for abscesses: a left lateral
abdominal wall collection measuring 13.7 x 11.6 x 3.0
cm that contained multiple foci of air, a left lower
quadrant collection measuring 8.1 x 3.6 x 2.8 cm, a
prevesical collection measuring 7.4 x 6.8 x 1.3 cm, and
a right lower quadrant collection anteriorly measuring
7.8 x 0.9 x 0.6 cm. On hospital day two, interventional
radiology placed drainage catheters into the left lateral
and left lower quadrant collections. Cultures grew
moderate to heavy growth multi-drug resistant
Klebsiella pneumoniae (Figure 1).
The patient remained stable and white blood cell count
trended down. He continued to receive ertapenem. He
was discharged on day three with plans to follow-up
with interventional radiology for drain removal.

Figure 1. Antibiotic sensitivities for the Klebsiella pneumonia isolate
aspirated from the patient’s intra-abdominal abscesses.

REVIEW OF LITERATURE
Under normal physiologic conditions, PCT is a
prohormone produced in the thyroid gland that is further
processed to yield calcitonin, one of the primary
hormones involved in calcium homeostasis. During
bacterial infections, other tissues begin expressing PCT
without processing it into calcitonin, or having detectable
effects on calcium homeostasis.3,4 While this finding has
raised considerable in the usage of PCT as a specific
marker of bacterial infections, the biological function of
extra-thyroidal PCT remains unknown.5
The Food and Drug Administration (FDA) has approved
the use of PCT assays as a guide for beginning and
discontinuing antibiotic therapy in suspected lower
respiratory tract infections.1 The FDA indication was
informed in part by a Cochrane review that found
PCT-guided antibiotic therapy in acute respiratory tract
infections reduced antibiotic usage and mortality risk.6
The FDA also approved using PCT to guide de-escalation
of antibiotics during sepsis.
Although PCT-guided antibiotic prescribing algorithms
are intended to decrease the use and duration of
antibiotics, data are mixed. Huang et al note two main
criticisms of existing clinical trials: that they were
conducted in Europe where antibiotic prescribing
practices may differ from the United States, and that
physicians could override the PCT-guided algorithms.7 To
address these criticisms, their group conducted a large
trial in the United States: finding that PCT-guided
algorithms did not change the number of antibiotic-days
patients received.7
There are only a few Infectious Disease Society of
America (IDSA) guidelines in which PCT appears. A 2016
IDSA guideline on antibiotic stewardship contains a weak
recommendation for serial PCT measurements for
guidance of antibiotic de-escalation in adult ICU patients.8
A 2017 IDSA guideline contains weak recommendations
for using serum PCT to differentiate between
cerebrospinal fluid abnormalities due to surgery or
intracranial hemorrhage vs. bacterial infection. The weak
recommendation also extends to healthcare-associated
bacterial ventriculitis and meningitis, which are based on
studies reporting serum PCT having 100% specificity for
bacterial meningitis.9-11 A separate 2016 IDSA guideline on
hospital-acquired pneumonia recommends against the
usage of PCT to initiate antibiotics. 12 IDSA 2007
community-acquired pneumonia guidelines do not
make recommendations for or against usage of PCT.
Data for the utility of PCT as it pertains to localized
infections and abscesses are limited. A review on PCT in
localized infections by Saeed, Ahmad, and Dryden
reported two small (<100 patients) studies showing
promise for using PCT to determine the need for
antibiotics in wound infection.13 The studies, however,

suffered major limitations including heterogeneous
samples in one and a lack of control group in the other.
PCT for diagnostic aide in diabetic foot infection had
mixed data with positive results appearing with low
thresholds (0.2-0.5 ng/mL). Data do not support usage of
PCT in diagnosis of septic arthritis and was not found to
be a reliable marker over several small studies in
osteomyelitis without sepsis.
Soderquist et al found patients with non-bacteremic
septic arthritis and crystal-induced arthritides had similar
PCT levels.14 Hammer et al found lower PCT levels in
localized infections when trying to discern between
infection and acute rejection in transplant recipients;
however, abscesses were not specified as one of the
localized infections studied.15 Gendrel et al found lower,
but still elevated, PCT levels in pediatric patients with
localized vs. generalized infections.16 In contrast, an
abstract published in 2013 reported PCT to be a specific
marker for intra-abdominal abscesses in Crohn’s disease
with a higher mean serum PCT compared to patients
without abscesses, however, ranges were not specified.17
Another study conducted in 10 patients on extracorporeal oxygen therapy—with one of them having an
abscess—concluded PCT performed well as an indicator
of infection.18

CASE DISCUSSION
The focus of this report is the normal-range PCT level in
the context of confirmed intra-abdominal bacterial
infection with evidence of a systemic response
(leukocytosis, hypothermia, elevated inflammatory
markers) and organ damage (acute kidney injury).
The case raises the question of the effect of hypothyroidism on PCT measurements, which is not well studied.
One study involving 24 patients who had received total
thyroidectomy for medullary thyroid carcinoma showed
that PCT was not decreased; however, fourteen patients
were found to have residual thyroid tissue on ultrasound,
eight had regional recurrence, and two had distant
metastases.19 In a study involving patients with Hashimoto’s
thyroiditis, those with Hashimoto’s had higher mean PCT
levels than controls, and PCT was positively correlated
with anti-thyroglobulin and anti-thyroid peroxidase
levels.20 Based on these data, there is either a paradoxical
effect on PCT levels or no effect at all, which is in
accordance with the understanding that PCT in infected
states is extra-thyroidal in nature.3,4
Another possible explanation for the false-negative is
antibiotic pre-treatment. Administration of antibiotics
prior to obtaining an initial PCT has been shown to lead
to lower PCT values. 21 This patient was receiving
ertapenem for seven days prior to his admission. It is
presumable that if PCT is intended to indicate a systemic
response to an infection as the literature so far shows,
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then values should still be elevated if the microbial burden
has not been decreased enough so as to temper that
systemic response (e.g. poor source control, inadequate
duration of treatment, etc.).
An additional, yet equally important consideration, is that
this patient may not have been septic. At first, this seemed
to be unlikely given the magnitude of the Gram-negative
microbial burden evidenced in the patient’s abdomen.
Such anatomically disparate foci of infection (left
abdominal wall, left lower quadrant, right lower quadrant,
pre-vescicular) suggests there may have been a recent
seeding event in the context of long-term indwelling
central venous access. Given the highly virulent nature of
Klebsiella pneumoniae, it should have produced a robust
and clinically obvious systemic response.22 However, by
the current “Sepsis-3” diagnostic criteria utilizing the
sequential organ failure assessment (SOFA) score, the
patient may have not met criteria.23 Although he was
diagnosed with acute kidney injury based on a creatinine
of 1.0 mg/dL increased from a previously known 0.7 mg/
dL, it did not meet the SOFA criterion of 1.2 mg/dL.
Clinically, he appeared to be severely malnourished and
wasted in appearance, so a prior creatinine of 0.7 mg/dL
documented some weeks before the current admission
may still have been above his true baseline; there were no
other values documented. As such, he was considered to
have a true acute kidney injury, though it may not have
been due to sepsis. Determination of his baseline mental
status was confounded by his underlying Lewy body
dementia, making a Glasgow coma score SOFA criterion
impossible to reliably obtain. Significantly, he had none of
the typical hemodynamic changes classically associated
with sepsis. Finally, despite the perilous locations of the
patient’s abscesses, they may have been walled off to the
extent that they were effectively localized.
A final consideration is the patient’s many herbal
supplements as possible confounders. Herbal extracts
often contain numerous compounds in varying amounts
that may or may not be relevant to a given clinical
scenario. As an example, one study found that ursolic
acid, one of the compounds in bearberry leaf extract, was
able to ameliorate acute kidney injury associated with
sepsis in mice.24 A thorough review of the potential impact
of each of these supplements on the patient’s clinical
presentation is beyond the scope of this work.
False-positive PCT occurrences greatly outnumber those
of false-negatives. Christ-Crain and Muller have compiled
a list of common clinical scenarios.25 This list is adapted
from their article and presented in Table 1. It should be
noted that regarding the elimination of PCT, the renal
system does not appear to play a significant role,
therefore, acute kidney injury is not thought to produce
false-positives.26,27 Table 2 provides a summary of test
characteristics found across some of the larger studies
performed. Performance usually varies with the threshold
value studied.
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Table 1. Clinical scenarios that may produce false-positive or falsenegative PCT values. Adapted from Christ-Crain and Muller, 2005.25

Table 2. Selected published analyses of PCT sensitivity and specificity.3,28-32

CONCLUSION
Serum PCT can be a useful addition to the diagnostic
armamentarium in the evaluation of bacterial infection.
Similar to other biomarkers, it should not be solely relied
on or supplant clinical judgement. While false-positive
scenarios are more common, careful consideration must
be given to possible false-negative scenarios as this case
demonstrates. Testing may prove useful in cases of
clinical uncertainty and a PCT-guided algorithm may be a
beneficial addition to an established antimicrobial
stewardship program.

CURRENT FDA INDICATIONS FOR
TEST USAGE
The current FDA recommendation for usage of the test in
lower respiratory tract infections is strong discouragement
of antibiotics for PCT levels less than 0.1 ng/mL, discouragement for 0.1 to 0.25 ng/mL, recommendation for 0.25
to 0.5 ng/mL, and strong recommendation for levels
greater than 0.5 ng/mL. Additionally, the current FDA
recommendation for usage of the test in sepsis is discontinuation recommended if PCT is less than or equal to 0.5
ng/mL or if the PCT levels have decreased by greater than
80% from peak value.1
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